Every 70 seconds someone in America develops Alzheimer’s. In 2050, experts project there will be nearly one million new cases annually.
The Alzheimer’s Association has developed TrialMatch, a confidential interactive tool that provides comprehensive clinical trial information and an individualized trial-matching service for people with Alzheimer’s disease and related dementias. New ways to detect, treat and prevent Alzheimer’s disease and related dementias come from these trials so it is important to get people registered in them.
According to the Association, clinical trials present an opportunity to play a more active role in their treatment – ultimately contributing to scientific discovery and benefiting future generations.